Morgan Stanley Raises UnitedHealth (UNH) Price Target to $531
Key Points
- Morgan Stanley raised its price target on UnitedHealth Group to $531, up from $529, on October 27, 2026.
- Morgan Stanley's $531 price target implies 29.29% upside from UnitedHealth Group Incorporated's ($UNH) current $410.70 share price.
- UnitedHealth stock recently traded at $410.70, about equal to its closing price of $410.70 on October 26.
- The stock is currently below both the mean analyst target of $476.56 and the consensus recommendation of 'buy'.
Get UnitedHealth Group Incorporated text alerts
We text you when insiders, Congress, analysts or big funds move on $UNH.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated UnitedHealth Group Incorporated alert may contain errors. Disclosures
On October 27, 2026, Morgan Stanley raised its price target on UnitedHealth Group Incorporated (UNH) to $531 from $529. This change reflects Morgan Stanley's continued confidence in the company's growth potential. The firm maintains an 'Overweight' rating on the stock, suggesting they expect it to outperform the market.
UNH
UnitedHealth Group Incorporated
Morgan Stanley vs. the S&P 500
Hypothetical returns from Morgan Stanley's disclosed trades, not real profit or advice. How we model this.
Other Institutional Activity in UnitedHealth Group
Several institutional investors have made adjustments to their positions in UnitedHealth Group. Simplicity Wealth, LLC reduced its holdings by 12,048 shares, leaving it with 19,619 shares valued at about $7.2 million. Mondrian Investment Partners also cut its stake by 152,561 shares, resulting in a total of 218,096 shares worth approximately $80.1 million. Penn Davis Mcfarland trimmed its position by 2,777 shares, bringing its total to 133,482 shares valued at about $49 million. Wilmington Savings Fund Society, FSB decreased its holdings by 3,741 shares, ending with 13,600 shares worth around $4.99 million.
UnitedHealth Group Incorporated Stock Down 1.8%
UnitedHealth shares recently traded around $410.70, which is about equal to the closing price of $410.70 on October 26, 2026. The stock is currently above its 50-day moving average of $388.75 and its 200-day moving average of $361.35, indicating a strong performance trend. However, it is still about 11% below its 52-week high of $461.62.
$UNH price target
UnitedHealth Group Incorporated daily closes and this analyst's $531 target. Not advice.
Recent Earnings
UnitedHealth reported trailing twelve-month revenue of $450.1 billion, with a net margin of 3.5% and a return on equity of 15.8%. The company is scheduled to announce its next earnings report on January 12, 2027.
Insider Buying and Selling at UnitedHealth Group Incorporated
There have been recent insider sales at UnitedHealth. Patrick Hugh Conway, an officer at the company, sold 500 shares at an average price of $410.00 on August 5, 2026, totaling $205,000. Earlier, he sold 1,169 shares at $390.00 on August 21, 2026, amounting to $455,910.
Analysts Set New Price Targets
On October 27, 2026, Morgan Stanley maintained its 'Overweight' rating on UnitedHealth with a new price target of $531, up from $529. Other firms, including Bernstein and JP Morgan, have maintained their ratings as well, with targets of $500 and $524, respectively. The average analyst target stands at $476.56, reflecting a consensus recommendation of 'buy'.
About UnitedHealth Group
UnitedHealth Group Incorporated is a major healthcare company operating in the U.S. and internationally. It has four segments: Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, providing a range of health services and insurance plans.
Bottom Line
Investors should monitor UnitedHealth's upcoming earnings announcement on January 12, 2027, and keep an eye on further analyst updates that may impact the stock's performance. Morgan Stanley's recent price target increase may signal ongoing confidence in the company's growth trajectory.
Related Filing Alerts
Source: Morgan Stanley's rating change on $UNH (Oct 27, 2026). Written by software, not financial advice. How we make alerts